Pharmacist-led care pathway for type 2 diabetes in Alberta community pharmacies
Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies.
NA · University of Alberta · NCT07339852
This project will test whether a pharmacist-led care pathway in community pharmacies can help adults with type 2 diabetes and HbA1c above 7.0% lower their blood sugar and improve care compared with usual physician or nurse practitioner care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Alberta (other) |
| Locations | 1 site (Edmonton, Alberta) |
| Trial ID | NCT07339852 on ClinicalTrials.gov |
What this trial studies
Adults with type 2 diabetes whose HbA1c is not at target will be enrolled and receive a structured pharmacist-led diabetes care pathway in community pharmacies. Pharmacists will provide medication review, shared decision-making, education, monitoring and follow-up visits, and coordinate with patients' primary care providers. Outcomes will include changes in HbA1c and management of cardiovascular risk factors such as blood pressure and lipids, measured over scheduled follow-ups. Results will be compared to usual care to see if the pharmacist-led approach improves glucose control and care processes.
Who should consider this trial
Good fit: Adults aged 18 or older with type 2 diabetes whose HbA1c is above 7.0% and who can consent and attend follow-up visits are the intended participants.
Not a fit: People with type 1 or gestational diabetes, pregnant individuals, those already at HbA1c target under 7.0%, those with limited life expectancy or frailty, or those unable to consent or attend follow-ups are unlikely to benefit from participating.
Why it matters
Potential benefit: If successful, this could make it easier for people with type 2 diabetes to reach target blood sugar levels and lower their risk of diabetes-related complications.
How similar studies have performed: Previous pharmacist-led interventions have shown modest to meaningful improvements in HbA1c and medication management, so this approach builds on existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individuals aged 18 years or older. 2. Individuals with type 2 diabetes. 3. Individuals with type 2 diabetes not reaching HbA1c target of under 7.0% Exclusion Criteria: 1. Individuals with type 1 diabetes, gestational diabetes, or other forms of diabetes that are not type 2 diabetes. 2. Pregnant individuals. 3. Individuals at their HbA1c target (HbA1c under 7.0%) or those with a limited life expectancy, frailty, or lack hypoglycemic awareness (i.e., those with an A1c target above 7.0%) . 4. Individuals unable to provide consent or who are unwilling to attend follow-up visits.
Where this trial is running
Edmonton, Alberta
- University of Alberta — Edmonton, Alberta, Canada (RECRUITING)
Study contacts
- Principal investigator: Ross Tsuyuki, BScPharm, PharmD, MSc — University of Alberta
- Study coordinator: Stephanie Gysel, BScPharm, PharmD
- Email: sgysel@ualberta.ca
- Phone: 403-993-6678
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus, Hypertension, Hyperlipidaemia, diabetes, pharmacist, pathway, shared decision making